Bristol-Myers Squibb Announces Leadership Changes
December 13 2019 - 7:00AM
Business Wire
- Kathryn Metcalfe Appointed Executive Vice President,
Corporate Affairs
- Tim Power Appointed Vice President and Head of Investor
Relations
- John Elicker to Retire in March 2020
Bristol-Myers Squibb Company (NYSE:BMY) announced today that
John Elicker, Executive Vice President, Corporate Affairs and
Investor Relations, will retire from the company March 31, 2020.
Kathryn Metcalfe, currently Chief Communications Officer of CVS
Health, has been appointed Executive Vice President, Corporate
Affairs, effective January 6, 2020. Tim Power has been appointed
Vice President and Head of Investor Relations, effective March 31,
2020 upon Elicker’s retirement.
“On behalf of the company, I want to thank John for his
leadership and the important contributions he’s made in his many
years with Bristol-Myers Squibb,” said Giovanni Caforio, Chairman
and Chief Executive officer, Bristol-Myers Squibb. “He has
contributed to developing and executing our company strategy and
has built a strong Corporate Affairs and Investor Relations team
well positioned to continue to engage stakeholders around our
company strategy, the performance of our business and our
patient-focused mission.
“Kathryn is an accomplished and respected communications leader
and I look forward to her leadership of the company’s
communications at a time of growth and change for Bristol-Myers
Squibb,” said Caforio. “She will play an important role on the
leadership team as we engage with a broad range of stakeholders
around our business, the promise of our pipeline and the exciting
opportunities we are pursuing for patients.
“Tim is highly qualified to lead our Investor Relations team and
I look forward to his leadership during an important time for the
company,” he continued, “Tim has been instrumental in the company’s
strategic positioning and communicating our financial, strategic,
operational and business goals to investors and other key
stakeholders.”
Metcalfe will report to Caforio and will sit on the
Bristol-Myers Squibb leadership team. She will be responsible for
leading the company’s strategic communications across stakeholder
groups, including internal/external, global advocacy, state and
federal government affairs and global policy.
Power will continue to report to Elicker until his retirement in
March 2020, at which time Power will report to David Elkins,
Executive Vice President and Chief Financial Officer. Power will
lead all communications and engagement with the investment
community.
Metcalfe joins Bristol-Myers Squibb from CVS Health, where she
led communications following CVS’ acquisition of Aetna, where she
was chief communications officer. At CVS Health, Metcalfe oversaw
all strategic communications, internal and external, including
reputation, and crisis management. Prior to CVS, Metcalfe held
several senior Communications roles, including the Chief
Communications Officer at Deloitte, and senior roles at Novartis
and Pfizer as well as leadership roles at biotech and healthcare
communications firms.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube, Facebook, and
Instagram.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191213005070/en/
MEDIA: MEDIA@BMS.COM 609-252-3345
INVESTORS: TIM POWER, 609-252-7509, TIMOTHY.POWER@BMS.COM
NINA GOWOREK, 908-673-9711, NGOWOREK@CELGENE.COM
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Sep 2023 to Sep 2024